-
News | 2019.04.04
The 2019 "Prince Albert II of Monaco - Institut Pasteur" Prize is awarded to Joacim Rocklöv
During the Monaco Ocean Week*, on Thursday 28 March, His Serene Highness, the Sovereign Prince Albert II, in the presence of Professor Stewart Cole, Director General of the Institut Pasteur, awarded the "Prince Albert II of Monaco - Institut Pasteur" prize to Professor Joacim Rocklöv for his research work on climate-related arbovirus epidemics. Since 2012, this prize has been awarded to...
-
Page avancée | 2019.04.04
2018 Thesis and Ceremony
2018 Thesis and Ceremony
-
News | 2019.04.01
Immune cells fighting blood cancer visualized for the first time
When cancer escapes the immune system, our defenses are rendered powerless and are unable to fight against the disease. Chimeric antigen receptor T cells (CAR T cells) represent a promising immunotherapy strategy, developed with the aim of tackling tumors head-on. But the occurrence of relapse in some patients remains a challenge. Scientists at the Institut Pasteur have identified the precise...
-
News | 2019.04.10
Innate immune responses – redefining how innate lymphoid cells develop
The innate immune response represents an important natural process providing a critical line of defense against infection and cancer. Innate lymphoid cells (ILCs) play a key role in this early immune response. Researchers at the Institut Pasteur's Innate Immunity Unit (Inserm U1223) examining how these cells develop have identified new ILC precursors. This discovery constitutes a revolution for...
-
News | 2019.04.09
Meningitis: analysis of the long-term protection of the MenAfriVac vaccine
Frequent and major outbreaks of meningococcal meningitis have swept through countries in the "African meningitis belt", a region south of the Sahara that stretches from Senegal to Ethiopia, for over a century. To tackle this public health emergency, a group A polysaccharide tetanus toxoid conjugate vaccine (also called MenAfriVac) was developed against meningococcus. Using data from several...
-
Article | 2019.04.12
Memberships and Partners
Renewal of the status of the association Pasteur International Network as a "non-State actor in official relations" with WHO
-
Report | 2019.04.15
Autism: a unique event at the Institut Pasteur
On Saturday March 30, nearly 550 people came to the Institut Pasteur for a day focusing on the latest progress in research by the Institut Pasteur and Robert Debré Hospital on autism and autism spectrum disorder. This unique event also included a presentation of "Autisme Info Service", France's first free national platform for support and information on autism launched in April 2019, and a...
-
News | 2019.04.16
Microbiota and solid food introduction: interview with Gérard Eberl
Scientists from the Institut Pasteur and Inserm have discovered that a key immune response is generated when solid food is introduced and microbiota expands. Interview with Gérard Eberl, Head of the Microenvironment and Immunity Unit (Institut Pasteur / Inserm) and lead author of the study.Microbes colonize all body surfaces and help to balance the immune system. In newborn infants, gut...
-
Document de presse | 2019.04.17
The overall annual cost of infections due to bacterial resistance in French hospitals now estimated up to 290 million Euros
A team of researchers from Versailles Saint-Quentin-en-Yvelines University (UVSQ), Inserm and Pasteur Institute (Unité Mixte de Recherche 1181 Biostatistique, biomathématique, pharmacoépidémiologie et maladies infectieuses – B2PHI) has been able to provide for the first time an accurate estimate of both the incidence (annual number of new cases) and added direct cost of infections due to...
-
Article | 2019.04.24
Dr Amy Kristine Bei to head a new 4-year research group on malaria in Dakar
A new 4-year research group (G4) is being set-up at the Institut Pasteur de Dakar and started in early February following the agreement signed between the Institut Pasteur and AUF (Agence universitaire de la francophonie) on 31 January 2019, in collaboration with the Yale School of Public Health. Entitled « Malaria Experimental Genetic Approaches and Vaccines », it will be led by...
